908 Devices Inc

908 Devices Inc (MASS) Stock Analysis

$10.670

+0.481 (+4.51%)At close

Loading chart…
High
10.930
Open
10.350
VWAP
10.60
Volume
308.56K
Mkt Cap
177.60M
Low
10.210
Amount
3.27M
EV/EBITDA, TTM
-12.98

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.

AI analysis of 908 Devices Inc (MASS)

Hold

While 908 Devices Inc. (MASS) has shown a remarkable year-to-date change of +100.59%, the current price of $10.21 is below the average analyst price target of $12.75, suggesting potential upside. However, the RSI is at 26.067, indicating that the stock is oversold, which may signal a potential rebound. The main risk is the recent 5-day change of -12.36%, reflecting volatility and potential downward pressure.

Valuation Metrics

The current forward P/E ratio for 908 Devices Inc (MASS) is 0.00, compared to its 5-year average forward P/E of -9.76.

Forward P/E

Overvalued
5Y Average P/E
-9.76
Current P/E
0.00
Overvalued
-2.60
Undervalued
-16.92

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-7.54
Current EV/EBITDA
-12.98
Overvalued
2.10
Undervalued
-17.18

Forward P/S

Fair
5Y Average P/S
5.84
Current P/S
5.11
Overvalued
9.89
Undervalued
1.79

Alphio AI Price Scenarios for MASS

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%MASS

$6.47

Scenario price

B

Base

Base · 50%MASS

$6.04

Scenario price

B

Bear

Bear · 25%MASS

$5.05

Scenario price

Whales holding MASS

A

Arch Venture Partners, L.P.

+ HoldingMASS

-18.10%

3M Return

Events Timeline

2026-08-11 (ET)

07:30:00

Q2 Revenue of $16.1M Exceeds Expectations

2026-05-06 (ET)

07:40:00

Company Reports Q1 Revenue of $13.4M, Acquires NIRLAB AG

07:30:00

908 Devices Completes Acquisition of NIRLAB AG for $15 Million

2026-04-21 (ET)

17:10:00

908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer

2026-03-09 (ET)

07:00:00

908 Devices Files $100M Mixed Securities Shelf

News

MASS FAQ — answered by Alphio AI

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds. It operates in the Healthcare sector (MEASURING & CONTROLLING DEVICES, NEC industry).

While 908 Devices Inc. (MASS) has shown a remarkable year-to-date change of +100.59%, the current price of $10.21 is below the average analyst price target of $12.75, suggesting potential upside. However, the RSI is at 26.067, indicating that the stock is oversold, which may signal a potential rebound. The main risk is the recent 5-day change of -12.36%, reflecting volatility and potential downward pressure.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading